Power Law company profile

Janux Therapeutics

Biotech & Life Sciences · San Diego, United States · Founded 2017 · IPO 2021 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Revenue

$10.0M

Latest reported FY

Investors

12 investors on Janux Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 5 investors entered at this stage

Avalon Ventures

Correlation Ventures

Bregua Corporation

RA Capital Management

OrbiMed

Series B+ 7 investors entered at this stage

BVF Partners

Hartford HealthCare Endowment

Logos Capital

Janus Henderson Investors

EcoR1 Capital

Citadel

Samsara BioCapital

Global footprint

Where Janux Therapeutics has talent and traffic

Web traffic by country

11K monthly visits
across markets

🇺🇸 United States80.9%

🇬🇧 United Kingdom9.1%

🇯🇵 Japan6.4%

🇮🇳 India0%

Top 4 markets shown

Patent intelligence

$2M patent portfolio · 29 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$2M

947.3× smaller than top peer Ablynx ($2B)

29 active patent families

Where Janux Therapeutics innovates Molecular biologyPharmaceutical drugAntibody targetingEffector cellNucleic acid

Below peer median on Legal, Market

Quality vs same-sector peers

Janux Therapeutics on the five Patsnap quality dimensions

Janux Therapeutics in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Janux Therapeutics concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Janux Therapeutics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Janux Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo